Into This World We're Thrown
NCT04842812
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: HER2, Mesothelin+, MUC1, GPC3, LeY, AXL, EGFR, ROR1+, GD1/2, B7-H3
Breast Cancer Tissue:
Recruitment Status: Recruiting
Phase 1
Drug Category: Immunotherapy
Gender: All
Age: 18 Years to 85 Years (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes:
Exclusions:
https://ClinicalTrials.gov/show/NCT04842812
NCT04695847
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: MUC1, EGFR
Breast Cancer Tissue:
Recruitment Status: Recruiting
Phase 1
Drug Category: Immunotherapy, Therapeutic Antibody
Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases:
Additional Notes: Breast cancer patients are only eligible for Part 1
Exclusions: Patients with known brain metastasis
https://ClinicalTrials.gov/show/NCT04695847